SEC Form D · filed January 15, 2020
EYEGATE PHARMACEUTICALS INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Thomas Hancock · Waltham, MADirectorKeith Maher · Waltham, MADirectorSarah Romano · Waltham, MAExecMorton Goldberg · Waltham, MADirectorPaul Chaney · Waltham, MADirectorSteven Boyd · Waltham, MADirectorBernard Malfroy-Camine · Waltham, MADirectorPraveen Tyle · Waltham, MADirectorStephen From · Waltham, MAExec · DirectorJustin Jory · Woodbridge, VADirectorDaniel Wachtler · Redmond, WADirectorRodney D. Brown · LEESBURG, VAExec · DirectorJay Lee · Redmond, WADirectorRandy H. Hopkins · Meridian, IDDirectorTony Wood · Vancouver, British Columbia, CanadaDirectorTom Bruderman · Redmond, WADirectorDavid Wurtzbacher · Woodbridge, VAExecScott Fletcher · Ross, CADirectorBrian Mcveigh · Hatfield, PADirectorJohn Iadeluca · New York, NYDirectorAccumulus Capital Partners, LLC · New York, NYDirectorSoutheast Asset Advisors, LLC · Thomasville, GADirectorAmir Nashat · CAMBRIDGE, MADirectorPaula Ragan · CAMBRIDGE, MADirectorRichard Young · CAMBRIDGE, MAExecJosh Mandel-Brehm · CAMBRIDGE, MAExec · DirectorJoshua G. Kazam · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗